Failure to suppress α-cell glucagon secretion is another hallmark of IR, and consistent with this, NGOB and T2D plasma glucagon levels were similarly elevated compared to WT controls (Figure 4B). The gene discussed is GCG; the disease is type 2 diabetes mellitus.